DOI 10.1016/j.ijbiomac.2026.151393
Construction and validation of an osteosarcoma prognostic model reveals that SERPINE2 contributes to the progression and cisplatin sensitivity in osteosarcoma.
Аннотация
Osteosarcoma (OS) is a common malignant tumor which lacks robust biomarkers for prognosis and treatment stratification. This research aims to construct a predictive gene signature in OS with prognostic and therapeutic implications. We downloaded from TARGET-OS and GEO databases and obtained 298 differentially expressed genes (DEGs) by analysis of variance. The prognosis model, including multiple genes, was successfully constructed. We identified three molecular subtypes with distinct phenotypes, immune microenvironment profiles, and pathway enrichment patterns. The characteristics of the prognostic model included seven genes (FRZB, MX1, PTN, GRP, ITK, MYC, SERPINE2). Among these genes, SERPINE2 was prioritized for experimental validation; SERPINE2 knockdown suppressed osteosarcoma cell growth and invasion and increased cisplatin-induced DNA damage. Collectively, our results support an integrative prognostic model for OS and suggest SERPINE2 as a candidate modulator of tumor progression and cisplatin resistance.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.